State of providing oncological aid to the population of Ukraine in wartime conditions

Abstract

Annotation. The fight against oncological diseases remains one of the priority directions of the health care system of Ukraine, yet this process has become much more complicated in the conditions of martial law. In order to study the state of providing oncological care to the population of Ukraine in wartime conditions, information from the National Health Service of Ukraine was studied. The distribution of oncological treatment service providers by regions and by ownership was performed, the level of hospitalizations per 100,000 individuals and the available bed fund per 1 million individuals were analyzed. Statistical methods (analysis of relative values, calculation of the correlation coefficient), structural-logical analysis and systematic approach are applied. The research established that, as of July 2022, 103 institutions (including 7 private ones) provide chemotherapeutic treatment services, and 35 institutions (including 2 private ones) provide radiological treatment services. The largest number of chemotherapeutic treatment providers per 1 million individuals is located in Kirovohrad region, the smallest – in Kyiv region. Meanwhile, Zaporizhia and Kirovohrad regions are characterized by the largest number of radiological treatment providers per 1 million individuals, while Odesa and Kharkiv regions have the lowest number. The largest number of oncology beds per 1 million individuals and the largest number of hospitalizations per 100,000 individuals were registered in the city of Kyiv and in Poltava region, the lowest – in Luhansk region. When organizing the provision of oncological care to the population in wartime conditions, the factor of cross-border treatment, as well as the use of telemedicine programs, must be taken into account. Further research is required to study the impact of the military conflict on oncology risk, the level of morbidity, mortality and neglect of cancer in the population of Ukraine.